Clinical Trial Update: A Study of ELX-02 in Patients With Alport Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating ELX-02 in patients with Alport Syndrome has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alport Syndrome

Drugs mentioned

• ELX-02 (ELX-02)

Snippet

Sponsor: Eloxx Pharmaceuticals, Inc. | Conditions: Alport Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2026-02-24